Merit Financial Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$616K	Sell	1,890 -3,424	-64%	-$1.12M	0.01%	1003
2025 Q1	$1.43M	Buy	5,314 +2,819	+113%	+$761K	0.02%	521
2024 Q4	$587K	Buy	+2,495	New	+$587K	0.01%	666
2024 Q3	–	Sell	-928	Closed	-$226K	–	831
2024 Q2	$226K	Buy	+928	New	+$226K	0.01%	827